Research ArticleArticle

Increased Serum Interleukin 22 in Patients with Rheumatoid Arthritis and Correlation with Disease Activity

LAURINDO FERREIRA da ROCHA Jr, ÂNGELA LUZIA BRANCO PINTO DUARTE, ANDRÉA TAVARES DANTAS, HENRIQUE ATAÍDE MARIZ, IVAN da ROCHA PITTA, SUELY LINS GALDINO and MAIRA GALDINO da ROCHA PITTA
The Journal of Rheumatology July 2012, 39 (7) 1320-1325; DOI: https://doi.org/10.3899/jrheum.111027

REFERENCES

  1. 1.↵
    1. Hochberg MC,
    2. Smolen JS,
    3. Weinblatt ME,
    4. Weisman MH
    1. Liao KP,
    2. Karlson EW
    . Classification and epidemiology of rheumatoid arthritis. In: Hochberg MC, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 5th ed. Vol. 1. Philadelphia: Elsevier; 2011:823–7.
    OpenUrlFREE Full Text
  2. 2.↵
    1. McInnes IB,
    2. Schett G
    . Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007;7:429–42.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Firestein GS
    . Evolving concepts of rheumatoid arthritis. Nature 2003;423:356–61.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lubberts E
    . IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis? Cytokine 2008;41:84–91.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Gaston JS
    . Cytokines in arthritis — The ‘big numbers’ move centre stage. Rheumatology 2008;47:8–12.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Murphy CA,
    2. Langrish CL,
    3. Chen Y,
    4. Blumenschein W,
    5. McClanahan T,
    6. Kastelein RA,
    7. et al.
    Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003;198:1951–7.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Hirota K,
    2. Hashimoto M,
    3. Yoshitomi H,
    4. Tanaka S,
    5. Nomura T,
    6. Yamaguchi T,
    7. et al.
    T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007;204:41–7.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Cho ML,
    2. Kang JW,
    3. Moon YM,
    4. Nam HJ,
    5. Jhun JY,
    6. Heo SB,
    7. et al.
    STAT3 and NF-kappa B signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol 2006;176:5652–61.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Manel N,
    2. Unutmaz D,
    3. Littman DR
    . The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor ROR gamma-t. Nat Immunol 2008;9:641–9.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Volpe E,
    2. Servant N,
    3. Zollinger R,
    4. Bogiatzi SI,
    5. Hupe P,
    6. Barillot E,
    7. et al.
    A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008;9:650–7.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Gaffen SL
    . Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009;9:556–67.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Ghoreschi K,
    2. Laurence A,
    3. Yang XP,
    4. Tato CM,
    5. McGeachy MJ,
    6. Konkel JE,
    7. et al.
    Generation of pathogenic T(H)17 cells in the absence of TGF-ß signalling. Nature 2010;467:967–71.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Wolk K,
    2. Sabat R
    . Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006;17:367–80.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Zenewicz LA,
    2. Flavell RA
    . Recent advances in IL-22 biology. Int Immunol 2011;23:159–63.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Xie MH,
    2. Aggarwal S,
    3. Ho WH,
    4. Foster J,
    5. Zhang Z,
    6. Stinson J,
    7. et al.
    Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000;275:31335–9.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Kotenko SV,
    2. Izotova LS,
    3. Mirochnitchenko OV,
    4. Esterova E,
    5. Dickensheets H,
    6. Donnelly RP,
    7. et al.
    Identification of the functional interleukin-22 (IL-22) receptor complex: The IL-10R2 chain (IL-10R-beta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001;276:2725–32.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Liang SC,
    2. Tan XY,
    3. Luxenberg DP,
    4. Karim R,
    5. Dunussi-Joannopoulos K,
    6. Collins M,
    7. et al.
    Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271–9.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Andoh A,
    2. Zhang Z,
    3. Inatomi O,
    4. Fujino S,
    5. Deguchi Y,
    6. Araki Y,
    7. et al.
    Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005;129:969–84.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Ikeuchi H,
    2. Kuroiwa T,
    3. Hiramatsu N,
    4. Kaneko Y,
    5. Hiromura K,
    6. Ueki K,
    7. et al.
    Expression of interleukin-22 in rheumatoid arthritis: Potential role as a proinflammatory cytokine. Arthritis Rheum 2005;52:1037–46.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Leipe J,
    2. Schramm MA,
    3. Grunke M,
    4. Baeuerle M,
    5. Dechant C,
    6. Nigg AP,
    7. et al.
    Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2011;70:1453–7.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Shen H,
    2. Goodall JC,
    3. Hill Gaston JS
    . Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009;60:1647–56.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Shen H,
    2. Goodall JC,
    3. Gaston JS
    . Frequency and phenotype of T helper 17 cells in peripheral blood and synovial fluid of patients with reactive arthritis. J Rheumatol;37:2096–9.
  23. 23.↵
    1. Wolk K,
    2. Kunz S,
    3. Witte E,
    4. Friedrich M,
    5. Asadullah K,
    6. Sabat R
    . IL-22 increases the innate immunity of tissues. Immunity 2004;21:241–54.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Lavoie TN,
    2. Stewart CM,
    3. Berg KM,
    4. Li Y,
    5. Nguyen CQ
    . Expression of interleukin-22 in Sjogren’s syndrome: Significant correlation with disease parameters. Scand J Immunol 2011;74:377–82.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Cascao R,
    2. Moura RA,
    3. Perpetuo I,
    4. Canhao H,
    5. Vieira-Sousa E,
    6. Mourao AF,
    7. et al.
    Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther 2010;12:R196.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Geboes L,
    2. Dumoutier L,
    3. Kelchtermans H,
    4. Schurgers E,
    5. Mitera T,
    6. Renauld JC,
    7. et al.
    Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 2009;60:390–5.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Arnett FC,
    2. Edworthy SM,
    3. Bloch DA,
    4. McShane DJ,
    5. Fries JF,
    6. Cooper NS,
    7. et al.
    The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Prevoo ML,
    2. van ’t Hof MA,
    3. Kuper HH,
    4. van Leeuwen MA,
    5. van de Putte LB,
    6. van Riel PL
    . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Aletaha D,
    2. Nell VP,
    3. Stamm T,
    4. Uffmann M,
    5. Pflugbeil S,
    6. Machold K,
    7. et al.
    Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: Validation of a clinical activity score. Arthritis Res Ther 2005;7:R796–806.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Zhang L,
    2. Li JM,
    3. Liu XG,
    4. Ma DX,
    5. Hu NW,
    6. Li YG,
    7. et al.
    Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 2011;31:606–14.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Zhang N,
    2. Pan HF,
    3. Ye DQ
    . Th22 in inflammatory and autoimmune disease: Prospects for therapeutic intervention. Mol Cell Biochem 2011;353:41–6.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Eyerich S,
    2. Eyerich K,
    3. Cavani A,
    4. Schmidt-Weber C
    . IL-17 and IL-22: Siblings, not twins. Trends Immunol 2010;31:354–61.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Kochi Y,
    2. Suzuki A,
    3. Yamada R,
    4. Yamamoto K
    . Ethnogenetic heterogeneity of rheumatoid arthritis — Implications for pathogenesis. Nat Rev Rheumatol 2010;6:290–5.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Melis L,
    2. Vandooren B,
    3. Kruithof E,
    4. Jacques P,
    5. De Vos M,
    6. Mielants H,
    7. et al.
    Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis. Ann Rheum Dis 2010;69:618–23.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Yamada H,
    2. Nakashima Y,
    3. Okazaki K,
    4. Mawatari T,
    5. Fukushi JI,
    6. Kaibara N,
    7. et al.
    Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:1299–304.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Metawi SA,
    2. Abbas D,
    3. Kamal MM,
    4. Ibrahim MK
    . Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 2011;30:1201–7.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Duhen T,
    2. Geiger R,
    3. Jarrossay D,
    4. Lanzavecchia A,
    5. Sallusto F
    . Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009;10:857–63.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Trifari S,
    2. Kaplan CD,
    3. Tran EH,
    4. Crellin NK,
    5. Spits H
    . Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009;10:864–71.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Fujita H,
    2. Nograles KE,
    3. Kikuchi T,
    4. Gonzalez J,
    5. Carucci JA,
    6. Krueger JG
    . Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci USA 2009;106:21795–800.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Kagami S,
    2. Rizzo HL,
    3. Lee JJ,
    4. Koguchi Y,
    5. Blauvelt A
    . Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010;130:1373–83.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Hochberg MC SA,
    2. Smolen JS,
    3. Weinblatt ME,
    4. Weisman MH
    1. Dass S,
    2. Vital EM,
    3. Emery P
    . Rituximab. In: Hochberg MC SA, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 5th ed. Vol. 1. Philadelphia: Elsevier; 2011:563–95.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Hsu HC,
    2. Yang P,
    3. Wang J,
    4. Wu Q,
    5. Myers R,
    6. Chen J,
    7. et al.
    Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008;9:166–75.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Doreau A,
    2. Belot A,
    3. Bastid J,
    4. Riche B,
    5. Trescol-Biemont MC,
    6. Ranchin B,
    7. et al.
    Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009;10:778–85.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. van de Veerdonk FL,
    2. Lauwerys B,
    3. Marijnissen RJ,
    4. Timmermans K,
    5. Di Padova F,
    6. Koenders MI,
    7. et al.
    The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum 2011;63:1507–16.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Save to my folders

Jump to section